2-((S)-2-((S)-1-((S)-1-((S)-5-amino-2-(2-((S)-2-((S)-1-((S)-5-amino-2-(2-((S)-1-((S)-2-((S)-4-methyl-2-((S)-3-methyl-2-((S)-pyrrolidine-2-carboxamido)butanamido)pentanamido)-3-phenylpropanoyl)pyrrolidine-2-carboxamido)acetamido)-5-oxopentanoyl)pyrrolidine-2-carboxamido)-3-phenylpropanamido)acetamido)-5-oxopentanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)-4-methylpentanamido)acetic acid

ID: ALA5208013

Chembl Id: CHEMBL5208013

PubChem CID: 72200838

Max Phase: Preclinical

Molecular Formula: C76H111N17O18

Molecular Weight: 1550.82

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O

Standard InChI:  InChI=1S/C76H111N17O18/c1-43(2)36-51(65(100)82-42-63(98)99)85-71(106)57-25-16-34-92(57)76(111)58-26-17-35-93(58)74(109)50(28-30-60(78)95)84-61(96)40-80-66(101)53(38-46-18-9-7-10-19-46)86-70(105)56-24-15-33-91(56)73(108)49(27-29-59(77)94)83-62(97)41-81-69(104)55-23-14-32-90(55)75(110)54(39-47-20-11-8-12-21-47)88-68(103)52(37-44(3)4)87-72(107)64(45(5)6)89-67(102)48-22-13-31-79-48/h7-12,18-21,43-45,48-58,64,79H,13-17,22-42H2,1-6H3,(H2,77,94)(H2,78,95)(H,80,101)(H,81,104)(H,82,100)(H,83,97)(H,84,96)(H,85,106)(H,86,105)(H,87,107)(H,88,103)(H,89,102)(H,98,99)/t48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1

Standard InChI Key:  XKZOMGAAUPUXSS-HBQBBNSBSA-N

Associated Targets(non-human)

gag Structural capsid protein (291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1550.82Molecular Weight (Monoisotopic): 1549.8293AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Zhang X, Sun L, Meuser ME, Zalloum WA, Xu S, Huang T, Cherukupalli S, Jiang X, Ding X, Tao Y, Kang D, De Clercq E, Pannecouque C, Dick A, Cocklin S, Liu X, Zhan P..  (2021)  Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.,  226  [PMID:34592608] [10.1016/j.ejmech.2021.113848]

Source